Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals

被引:35
作者
Stuckey, Ashley [1 ]
Febbraro, Terri [1 ]
Laprise, Jessica [1 ]
Wilbur, Jennifer S. [1 ]
Lopes, Vrishali [1 ]
Robison, Katina [1 ]
机构
[1] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2016年 / 39卷 / 04期
关键词
genetic referral; breast cancer; BRCA mutation; BRCA2 MUTATION CARRIERS; RISK-ASSESSMENT; DIAGNOSIS; CONSULTATION; PHYSICIANS; KNOWLEDGE; IMPACT;
D O I
10.1097/COC.0000000000000073
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Genetic predisposition is responsible for 5% to 10% of breast cancer. The National Comprehensive Cancer Network (NCCN) established guidelines delineating appropriate candidates for genetic counseling. This study aims to determine referral patterns for genetic counseling in women who met such guidelines. Materials and Methods: Utilizing an institutional tumor registry, patients from an academic oncology program who met a subset of NCCN guidelines for genetic referrals between 2004 and 2010 were identified (breast cancer diagnosis <= 50 y without a known BRCA mutation). A retrospective chart review was conducted. Statistics were analyzed using SAS version 9.2. Results: A total of 314 patients were identified and 107 (34.1%) were referred for genetic counseling. Median age at diagnosis was younger for those referred versus not referred (43 and 46 y; P < 0.0001). Women were more likely referred with a family history suspicious for an inherited cancer syndrome (67.3% vs. 36.2%; P < 0.0001). There was no difference in stage at diagnosis, insurance, or race among women referred. Those patients who choose prophylactic contralateral mastectomy were likely to have been referred for genetic counseling (63.6% vs. 36.4%, P < 0.0001). Among patients referred, 77.6% consulted with a genetics counselor, 95.2% underwent genetic testing, and 16.5% had a BRCA mutation. Conclusions: Genetic counseling and testing is being underutilized in women who meet NCCN referral guidelines. Age and family history were noted to be predictive of referral for genetic evaluation. Further research is needed to determine additional factors that may impact not only referral rates but subsequent care for women with possible genetic predispositions to cancer.
引用
收藏
页码:363 / 367
页数:5
相关论文
共 50 条
[21]   Breast cancer in Zimbabwe: patterns of care and correlates of adherence in a national referral hospital radiotherapy center cohort from 2014 to 2018 [J].
Elmore, Shekinah Nefreteri Cluff ;
Mushonga, Melinda ;
Iyer, Hari Subramaniam ;
Kanda, Caroline ;
Chibonda, Shirley ;
Chipidza, Fallon ;
Makunike Mutasa, Rudo ;
Muchuweti, David ;
Muguti, Edwin G. ;
Maunganidze, Aspect ;
Ndlovu, Ntokozo ;
Bellon, Jennifer Ruth ;
Nyakabau, Anna Mary .
CANCER MEDICINE, 2021, 10 (11) :3489-3498
[22]   Perceived risk and adherence to breast cancer screening guidelines among women with a familial history of breast cancer: A review of the literature [J].
Walker, Meghan J. ;
Chiarelli, Anna M. ;
Knight, Julia A. ;
Mirea, Lucia ;
Glendon, Gord ;
Ritvo, Paul .
BREAST, 2013, 22 (04) :395-404
[23]   Professionals' knowledge, attitude and referral behaviour of preimplantation genetic diagnosis for hereditary breast and ovarian cancer [J].
Gietel-Habets, J. J. G. ;
de Die-Smulders, C. E. M. ;
Tjan-Heijnen, V. C. G. ;
Derks-Smeets, I. A. P. ;
van Golde, R. ;
Gomez-Garcia, E. ;
van Osch, L. A. D. M. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2018, 36 (02) :137-144
[24]   National Comprehensive Cancer Network guidelines compliance of a sarcoma service: A retrospective review [J].
Blank, Alan T. ;
Larson, Brandon Michael ;
Shaw, Sara ;
Wakefield, Connor J. ;
King, Tricia ;
Jones, Kevin B. ;
Randall, R. Lor .
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2020, 11 (06) :389-396
[25]   Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines Who Is at Risk? [J].
Blakely, Andrew M. ;
Comissiong, Danielle S. ;
Vezeridis, Michael P. ;
Miner, Thomas J. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08) :754-759
[26]   Adherence to breast screening guidelines and breast cancer mortality: a population cohort study [J].
Christensen, Rebecca A. G. ;
Anderson, Geoffrey M. ;
Kim, Shana J. ;
Aminoleslami, Arian ;
Brooks, Jennifer D. .
BREAST CANCER RESEARCH AND TREATMENT, 2025, 213 (01) :63-69
[27]   Survivorship care plans and adherence to breast and cervical cancer screening guidelines among cancer survivors in a national sample [J].
Santos-Teles, Marco ;
Modugu, Ganesh ;
Silva, Isabel C. ;
Bandera, Elisa V. ;
George, Mridula ;
Qin, Bo ;
Smith, Jonathan ;
Stephenson, Ruth ;
Mattes, Malcolm D. ;
Eskander, Mariam F. .
SUPPORTIVE CARE IN CANCER, 2024, 32 (12)
[28]   Trends in adherence to NCCN guidelines for breast conserving therapy in women with Stage I and II breast cancer: Analysis of the 1998-2008 National Cancer Data Base [J].
Patrick, Jilma L. ;
Hasse, Michelle E. ;
Feinglass, Joe ;
Khan, Seema A. .
SURGICAL ONCOLOGY-OXFORD, 2017, 26 (04) :359-367
[29]   Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations [J].
Foluso O. Ademuyiwa ;
Patricia Salyer ;
Yinjiao Ma ;
Sherri Fisher ;
Graham Colditz ;
Katherine Weilbaecher ;
Laura J. Bierut .
Breast Cancer Research and Treatment, 2019, 178 :151-159
[30]   Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations [J].
Ademuyiwa, Foluso O. ;
Salyer, Patricia ;
Ma, Yinjiao ;
Fisher, Sherri ;
Colditz, Graham ;
Weilbaecher, Katherine ;
Bierut, Laura J. .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (01) :151-159